Close menu X

News

Has COVID-19 Indefinitely Disrupted the Pharma Sales Model?

Has COVID-19 Indefinitely Disrupted the Pharma Sales Model?

17 August 2020

In March, COVID-19 halted face to face Pharma sales teams, as healthcare systems start to open up, we ask has the model been indefinitely changed? 

Read more
The Gene Therapy Revolution Has Arrived. But What’s Next?

The Gene Therapy Revolution Has Arrived. But What’s Next?

04 August 2020

Three gene therapies have been successfully been approved over the last 2 years, revolutionising the treatment of rare, detrimental diseases. The landscape is now blossoming with hundreds of gene therapies in clinical development.

Read more
Is the US Finally Ready for the Biosimilar Boom?

Is the US Finally Ready for the Biosimilar Boom?

20 July 2020

The emergence of biosimilars has provided promise of increased cost-savings and increased patient accessibility to biologics. However, this promise has not yet been realised in the US.

Read more
Managing cancer patients during the COVID-19 pandemic

Managing cancer patients during the COVID-19 pandemic

26 June 2020

COVID-19 has impacted all aspects of clinical care globally, including #cancer treatment. A delicate balance needs to be struck between mitigating risk of potential exposure and continuing to ensure access to #cancer treatment and clinical trials.

Read more
Welcome to our new CEO Chris Stevenson

Welcome to our new CEO Chris Stevenson

20 May 2020

We are thrilled to announce the appointment of Chris Stevenson as CEO, Chris transitions to this new role from his position on the board as a non-executive director.

Read more
COVID-19 Dissecting the Therapeutic and Vaccine Landscape

COVID-19 Dissecting the Therapeutic and Vaccine Landscape

28 April 2020

We take a look at where does the most promise lie amidst this rapidly evolving landscape and when will therapeutic studies yield firm evidence of clinical benefit.

Read more
Mindfulness Event

Mindfulness Event

03 April 2020

Maintaining our team's mental well-being is crucial during these challenges times. We recently hosted a well-received mindfulness session to help our team manage the added stress of social-distancing and working from home.

Read more
We are working from home

We are working from home

13 March 2020

With COVID-19 gaining momentum we have taken the decision to close our offices

Read more
Keep Calm and Carry on Researching

Keep Calm and Carry on Researching

09 March 2020

The impact of COVID-19 is being felt in every industry and market research is no different with face to face research at risk. But we have a fantastic toolbox of digital virtual methods for uncovering powerful insights.

Read more
Will PSMA-targeting diagnostics and therapeutics revolutionize Prostate Cancer care?

Will PSMA-targeting diagnostics and therapeutics revolutionize Prostate Cancer care?

29 January 2020

PSMA-based imaging is poised to be widely adopted as standard imaging practice in prostate cancer

Read more
Page 1 of 4 Next